Class IITerminated

Bimatoprost powder recall

FDA recall D-0386-2025 · initiated Mar 31, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations

Details

Product: Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY
Recalling company: Medisca Inc.
Classification: Class II
Status: Terminated
Type: Voluntary: Firm initiated
Distribution: US Nationwide.
Initiated: Mar 31, 2025
FDA report date: Apr 30, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0386-2025 ↗

← All drug recalls